The Ogun State Government, in collaboration with the Institute of Human Virology (IHV), has reaffirmed its commitment to reducing the prevalence of tuberculosis within the state. This commitment was highlighted by Dr. Elijah Ogunsola, the Executive Secretary of the Ogun State Primary Health Care Development Board, during a stakeholders’ meeting held on Wednesday.
The primary objective of the meeting was to review the progress of the tuberculosis control project and address the challenges encountered during its implementation. Dr. Ogunsola commended the stakeholders for their valuable contributions to the project. He encouraged them to continue leveraging their expertise and sharing their experiences and suggestions to enhance tuberculosis control efforts.
In her presentation, Olusola Taiwo, the State Programme Manager for Tuberculosis and Leprosy Control, reiterated the state government’s dedication to reducing tuberculosis prevalence. She acknowledged the progress made thus far but emphasized that significant challenges still exist. Taiwo called for increased collective action among stakeholders to effectively tackle the obstacles facing tuberculosis control initiatives in the state.
Adeyemi Ajayi, the State Manager of the Institute of Human Virology, shared insights on the Tuberculosis-Local Organising Network 3 (TB-LON 3) project, which is funded by the United States Agency for International Development (USAID). He noted that the involvement of the local health authority team has been crucial in supporting the tuberculosis control project, as they are more connected to the grassroots and better equipped to combat the disease and related health issues.
Dr. Atinuke Duze, speaking on behalf of the health secretaries, expressed gratitude for the efforts of the Abiodun-led administration in promoting a healthier population and environment in the state. She conveyed optimism that Ogun State would make significant strides in reducing tuberculosis prevalence and achieving its goal of becoming a tuberculosis-free state.
Comments are closed for this story.